I tuned into ResMed's quarterly earnings call this afternoon, and was generally impressed with RMD's performance over the quarter, along with the explanations for that strong performance put forth by senior management. One of the financial analysts on the call noted that the pace of new products ResMed is bringing to market seems to have picked up over the last year. ResMed's CEO, Kieran Gallahue, confirmed that this observation has some basis in fact, and spoke proudly of the products that await us in RMD's development pipeline. As a Sleep Apnea patient, I eagerly await the introduction of new products, and applaud the manufacturers for investing in innovative solutions to the problems that arise with Sleep Apnea therapy. I would voice one note of caution to ResMed and the other manufacturers: please don't introduce products for the sake of introducing products without bringing some real benefit to us, the patients. Often in the rush to increase market share and bring up profit margins, companies bring new products to market that don't need to be there, and that are actually worse than their predecessor products. Sometimes we users of the products are used as guinea pigs to test products that really aren't fully "baked" yet, and could use some additional R&D or technical improvements.
All that being said, I don't see this day as having come yet for Sleep Apnea products. At this point, the industry has so much progress to make that almost every new release represents a substantial improvement over its predecessor . I sincerely hope things stay that way.